Back to results
US 11,026,905 B2Granted
STAT3 inhibitors
AssigneesTvardi Therapeutics, Inc., Baylor College of Medicine
InventorsSofia De Achaval, David John Tweardy
Life of this patent
Estimating the term…
Abstract
Compounds as STAT3 inhibitors are described. A pharmaceutical composition comprising the same, methods of making the same, and a method for treating or preventing conditions such as cancer, chronic inflammation, and fibrosis using the same, are described.
Claims6
A pharmaceutical composition, comprising
- (a) a compound of Formula III,
- or a pharmaceutically acceptable salt thereof, and
- (b) a pharmaceutically acceptable carrier or diluent.
Dependencies are inferred from the claim text.